Saturday Rounds: Week of October 24–30, 2026

Attrition sorts the classes. Weekly Biotech Signal Review · Completed reporting week: October 24–October 30, 2026 · Published October 31, 2026 Report at a glance: Geron stopped a 327-patient Phase 3 on survival futility, Artiva ended its NK program and cut about 94% of staff,…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *